Bridging the gaps between Radiology, Urology & Oncology, Eigen improves healthcare and quality of life through innovative breakthroughs in image-guided disease diagnosis and treatment. Our ingenuity and foresight, coupled with our ongoing involvement with the scientific and medical communities, positions us at the vanguard of emerging technology used for detecting, localizing and managing prostate cancer. Eigen holds numerous patents in its growing intellectual property portfolio.

Eigen adheres to the highest standard in medical device regulatory compliance. We place great importance on effective risk management, as well as the best practices specific to safe medical device design, manufacture and installation. Demonstrating overall industry excellence, ISO 13485 certification aligns Eigen with international regulatory requirements and permits us to pursue sales and distribution in Canada, EU countries, other European countries, Latin America, Iran, Turkey, China, HK, Philippines, Korea, Turkey, India, Mexico in addition to our leading role throughout the USA.


Health Care

Health Diagnostics

Medical Devices

Eigen

Mahtab Damda

Dr Michael A.

Jennifer Pebe

Gary Carter

Shambhu Acharya

The Leadership Team at Eigen is responsible for steering the strategic direction of the company, ensuring adherence to regulatory compliance, and driving innovation in image-guided disease diagnosis and treatment. This team collaborates to uphold the highest standards of quality assurance and risk management while overseeing financial strategies and operational excellence. Their collective expertise positions Eigen as a leader in the medical technology sector, particularly in the fight against prostate cancer.

Leadership Team

Engineering Team

Research and Development

Leadership Team

About

Team members

Other teams at Eigen

Engineering Team

Research and Development